Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology
- 1 July 2006
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 102 (1) , 92-97
- https://doi.org/10.1016/j.ygyno.2005.11.032
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The role of lymphadenectomy in penile cancerUrologic Oncology: Seminars and Original Investigations, 2004
- Controversies in the management of metastatic melanoma to regional lymphatic basinsJournal of Surgical Oncology, 2004
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Long-Term Survival of Intermediate Risk Endometrial Cancer (Stage IG3, IC, II) Treated with Full Lymphadenectomy and Brachytherapy without TeletherapyGynecologic Oncology, 2001
- Occult Lymph Node Metastases Detected by Cytokeratin Immunohistochemistry Predict Recurrence in Node-Negative Endometrial CancerGynecologic Oncology, 2001
- Predictors of Distant Recurrence in Clinical Stage I or II Endometrial Carcinoma Treated by Combination Surgical and Radiation TherapyGynecologic Oncology, 1997
- Staging Laparotomy for Endometrial Carcinoma: Assessment of Retroperitoneal Lymph NodesGynecologic Oncology, 1995
- Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node SamplingGynecologic Oncology, 1995
- The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancerInternational Journal of Gynecologic Cancer, 1994
- Assessment of depth of myometrial invasion in endometrial adenocarcinomaGynecologic Oncology, 1990